---
title: "Mineralys Therapeutics (MLYS.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/MLYS.US/norm.md"
symbol: "MLYS.US"
name: "Mineralys Therapeutics"
parent: "https://longbridge.com/en/quote/MLYS.US.md"
datetime: "2026-03-15T16:23:49.306Z"
locales:
  - [en](https://longbridge.com/en/quote/MLYS.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MLYS.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MLYS.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/MLYS.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/MLYS.US/norm.md)


# Mineralys Therapeutics (MLYS.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.4002 | -0.5232 | -0.6612 | -0.7940 | -0.9797 |
| ROE | -22.37% | -33.20% | -52.84% | -63.38% | -91.45% |
| Revenue | - | - | - | - | - |
| Net income | -32.23M | -36.93M | -43.27M | -42.21M | -48.95M |
| Operating income | -38.28M | -41.13M | -46.75M | -44.45M | -51.77M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | - | 599.95M | 335.72M | 354.94M | 205.90M |
| Leverage | - | 1.04 | 1.07 | 1.04 | 1.08 |
| BVPS | - | 7.30 | 4.77 | 5.26 | 3.84 |
| Turnover | - | - | - | - | - |
| Cash & STI | - | 593.63M | 324.92M | 343.03M | 198.19M |
| Inv & Rec | - | - | - | - | - |
| LT assets | - | 7000.00 | 22000.00 | 38000.00 | 53000.00 |
| Net debt | - | -593.63M | -324.92M | -343.03M | -198.19M |

## Cash Flow Statement (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | - | -28.87M | -30.17M | -45.49M | -66.84M |
| Investing CF | - | -150.51M | -42.88M | -92.88M | 83.57M |
| Financing CF | - | 295.19M | 9.83M | 189.28M | 90000.00 |
| Free CF | - | -14.32M | -14.73M | -29.70M | -48.92M |
| OCF coverage | - | - | - | - | - |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | - | - | - | 0.0000 |